Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Management of Benign Prostatic Hyperplasia

Initial Management

  • Watchful waiting is the preferred management strategy for patients with mild symptoms and should be considered for those with moderate to severe symptoms who have not developed complications 1, 2, 3
  • During watchful waiting, patients should be monitored yearly with repeat evaluations 3
  • Simple lifestyle modifications can reduce symptom distress, including decreasing fluid intake at bedtime 2 and reducing caffeine and alcohol consumption 2

Medical Therapy Options

  • Alpha-blockers work by inhibiting alpha1-adrenergic-mediated contraction of prostatic smooth muscle, relieving bladder outlet obstruction 3
  • Recommended alpha-blockers include alfuzosin 2, doxazosin 2, and terazosin 2
  • These agents produce on average a 4-6 point improvement in AUA Symptom Index, which patients perceive as meaningful 2
  • Key differences between alpha-blockers: tamsulosin has a lower risk of orthostatic hypotension but a higher risk of ejaculatory dysfunction 3

Surgical Interventions

  • Surgical intervention is appropriate for patients with moderate-to-severe LUTS who have failed medical therapy 5
  • TURP remains the benchmark for surgical therapies due to published evidence of efficacy from randomized clinical trials with long-term follow-up 5
  • Complications of TURP include sexual dysfunction 6, bladder neck contracture 6, need for blood transfusion 6, UTI 5, and hematuria 5

Minimally Invasive Options

  • Transurethral Microwave Thermotherapy (TUMT) is a minimally invasive option 4
  • Transurethral Needle Ablation (TUNA) appears to be more effective than medical therapy but less effective than TURP 6

Prostatic Stents

  • Prostatic stents should be considered only in high-risk patients, especially those with urinary retention 5
  • Prostatic stents are associated with significant complications such as encrustation, infection, and chronic pain 5

Important Considerations

  • Prostate volume assessment helps predict natural history and response to therapy 3
  • Patients on alpha-blockers should be monitored for orthostatic hypotension, especially with first dose 2
  • Surgical decisions should consider the patient's prostate size, comorbidities, and surgeon's experience 5
  • Combination therapy with finasteride and doxazosin may have more adverse effects, including asthenia 4 and postural hypotension 1